Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar.
Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.
ICYMI Leader Board
Other Small Caps with announcements today:
White Cliff Minerals (ASX:WCN) has passed another regulatory approval in the permitting process at the Coppermine project in Canada after receiving a positive conformity determination for its licences from the Nunavut Planning Commission (NPC).
Pan Asia Metals (ASX:PAM) has been granted the second series of exploration concessions that cover an additional 100km2 of ground at its Tama Atacama lithium project in Chile.
Tambourah Metals (ASX:TMB) has landed an early win at the Haystack Well prospect within its Russian Jack project in WA’s Pilbara region after first pass rock sampling returned up to 7,910ppm lithium.
Health and wellness company Bioxyne (ASX:BXN) has disclosed group revenue of ~$2.56 million for Q2 FY24, propelling the company’s annualised sales run rate beyond $10 million with the primary contributor to this growth being its medicinal cannabis business.
Soft tissue repair company Aroa Biosurgery (ASX:ARX) has announced the first clinical study of its trademarked Enivo system is showing encouraging results in the management of dead space after a mastectomy.
Final assays from first pass-drilling and results of NT-government supported airborne electromagnetic (AEM) survey at the Desoto Resources (ASX:DES) Fenton project have confirmed the presence of a large gold system and new exploration targets for follow-up.
Assays from a recently completed drilling program at the Alma Metals (ASX:ALM) Briggs project in central Queensland has reconfirmed a shallow, higher-grade zone of copper-molybdenum mineralisation.
The only pure play AI technology-driven language service provider on the ASX Straker (ASX:STG) has continued to showcase its resilience in FY24 delivering a strong third quarter with stable revenue, record gross margins and ongoing profitability.
Legacy Minerals Holdings (ASX:LGM) has agreed to a $6m deal with S2 Resources (ASX:S2R) to farm out its highly prospective Glenlogan copper gold project in NSW’s mineral-rich Lachlan Fold belt, where porphyry deposits can turn in to massive low-opex mining operations.
Eagle Mountain Mining (ASX:EM2) has announced it will start a scoping study to define the technical and production pathway for its Oracle Ridge copper project in Arizona.
Clinical-stage biotech PharmAust (ASX:PAA) says the US Food and Drug Administration (FDA) Office of Orphan Products Development has requested additional data to support its orphan drug designation application for monepantel (MPL) to treat Motor Neurone Disease (MND) Amyotrophic Lateral Sclerosis (ALS).
Mako Gold (ASX:MKG) says due diligence for the acquisition of Goldridge Resources and its Konan project is progressing, while exploration work at its Napié project in Côte d’Ivoire is aimed at generating drill targets over its promising Tchaga North prospect.
Pantera Minerals (ASX:PFE) has provided a sneak peek into the potential of its Superbird lithium project in the prolific Smackover Formation after pencilling in an exploration target of just under 3Mt lithium carbonate equivalent.
At Stockhead we tell it like it is. While several companies mentioned in this story are Stockhead advertisers, they did not sponsor this article.
The post In Case You Missed It: Key approvals for resource play and Aroa looks to improve mastectomy surgery appeared first on Stockhead.
+ There are no comments
Add yours